COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02073994
Recruitment Status : Active, not recruiting
First Posted : February 28, 2014
Last Update Posted : June 16, 2020
Information provided by (Responsible Party):
Agios Pharmaceuticals, Inc.